novo nordisk lawsuits against compounding pharmacies semaglutide 2023 2024 2025 expands weight-loss drug compounders Novo Nordisk on Tuesday filed

Formation of benign tumors by stem cell deregulation

Advanced delivery platforms Biomimetic nanosystems Emerging evidence highlights the therapeutic potential of biomimetic nanoplatforms engineered through fusion of natural cellular membranes with synthetic nanoparticles (NPs) (Fig

Vision Loss (NAION) from Ozempic Use One of the most serious emerging concerns in Ozempic litigation is the potential link between GLP-1 drugs and a rare form of eye stroke called non-arteritic anterior ischemic optic neuropathy, or NAION

pmid:19564624

Patients with depression, anxiety, obsessive thinking, autism, medication sensitivity or treatment resistance can have very different biochemical patterns despite carrying the same MTHFR variant

Res Dev Disabil 35(6):12281236